U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C18H17N3O4
Molecular Weight 339.3453
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PINAFIDE

SMILES

[O-][N+](=O)C1=CC2=C3C(=CC=C2)C(=O)N(CCN4CCCC4)C(=O)C3=C1

InChI

InChIKey=GBOQUHPYCRYKGV-UHFFFAOYSA-N
InChI=1S/C18H17N3O4/c22-17-14-5-3-4-12-10-13(21(24)25)11-15(16(12)14)18(23)20(17)9-8-19-6-1-2-7-19/h3-5,10-11H,1-2,6-9H2

HIDE SMILES / InChI
Pinafide is a rodenticide and anti-protozoal agent. Pinafide shows strong cytostatic activity against both HeLa and KB cells and is moderately toxic to both mice and rats. It has been proved active against experimental tumors and shown to be inhibitor of two DNA viruses. Pinafide blocks cell growth by inhibiting DNA and RNA synthesis. It has been shown to bind to double-helical DNA by intercalation. Pinafide inhibited the activity of M. tuberculosis NAD⁺-dependent DNA ligase A at concentrations of 50 uM. At the chemical screening was found that pinafide inhibited B-Myb transcriptional activity in luciferase assays. The cross placental-barrier studies showed that 3H-pinafide was present in the 14-day fetuses.

Approval Year

PubMed

PubMed

TitleDatePubMed
Naphthalimides Selectively Inhibit the Activity of Bacterial, Replicative DNA Ligases and Display Bactericidal Effects against Tubercle Bacilli.
2017-01-17
A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.
2012-05
Fluorescence of chromatin DNA induced by antitumoral naphthalimides.
1997-05-01
The pharmacokinetics, tissue distribution, and biotransformation of a new class of antitumor agents: mitonafide and pinafide.
1986-10-01
In vitro action of three benzo (de) isoquinoline-1,3-dione derivatives against Trypanosoma cruzi.
1983-09-01
[Ultrastructural study of the effect of 2 derivatives benzo (de) isoquinoline-1,3-dione on Trypanosoma cruzi in vitro].
1983-05-01
[Antineoplastic drugs used as fluorochromes].
1982
Synthesis and mode(s) of action of a new series of imide derivatives of 3-nitro-1,8 naphthalic acid.
1980
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Rats data
Single dose - 20 mg/kg
Route of Administration: Other
Name Type Language
NSC-300289
Preferred Name English
PINAFIDE
INN  
INN  
Official Name English
pinafide [INN]
Common Name English
3-NITRO-N-(2-(1-PYRROLIDINYL)-ETHYL)NAPHTHALIMIDE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C582
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
Code System Code Type Description
SMS_ID
100000081957
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
CAS
54824-20-3
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
EPA CompTox
DTXSID20866443
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
NCI_THESAURUS
C76757
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
ChEMBL
CHEMBL46874
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
PUBCHEM
327045
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
FDA UNII
1OZ94FI615
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
EVMPD
SUB09850MIG
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
INN
5047
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
NSC
300289
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY
MESH
C019222
Created by admin on Mon Mar 31 18:02:40 GMT 2025 , Edited by admin on Mon Mar 31 18:02:40 GMT 2025
PRIMARY